This issue covers life sciences developments in the areas of intellectual property, regulatory, pricing and reimbursement, international trade, litigation, and competition that are of particular importance across Europe, Asia, and the United States. It also provides some of the latest information on Brexit.
Some of the subjects from this quarter include new China rules on cybersecurity, FDA guidance on food recalls, rulings on diagnostic claims, pricing investigations, and registration of medicines in Russia to name a few. As you will find, many of the subjects covered in this issue are ongoing and we will continue to keep you updated on developments. The Life Sciences International Review team continues to monitor developments and will include updates in future issues to keep our readers current with the latest events and trends in the life sciences industry.
Read the full Q4 2018 issue of Life Sciences International Review here.